Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
63,751,521
-
Shares change
-
+1,019,407
-
Total reported value, excl. options
-
$8,776,308,689
-
Value change
-
+$115,863,512
-
Put/Call ratio
-
272%
-
Number of buys
-
113
-
Number of sells
-
-103
-
Price
-
$137.67
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2024
268 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2024.
Ascendis Pharma A/S - ADR (ASND) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63,751,521 shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10,112,744 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (5,528,239 shares), Avoro Capital Advisors LLC (5,103,055 shares), FMR LLC (4,728,647 shares), Artisan Partners Limited Partnership (4,450,420 shares), JANUS HENDERSON GROUP PLC (4,380,382 shares), Capital International Investors (2,863,249 shares), T. Rowe Price Investment Management, Inc. (2,725,546 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,283,207 shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1,867,551 shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.